Bamco Inc. NY Cuts Stock Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

Bamco Inc. NY lessened its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 52.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 40,000 shares of the company’s stock after selling 45,000 shares during the quarter. Bamco Inc. NY’s holdings in Surgery Partners were worth $1,290,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in the stock. Quarry LP boosted its holdings in Surgery Partners by 133.1% in the second quarter. Quarry LP now owns 3,082 shares of the company’s stock valued at $73,000 after acquiring an additional 1,760 shares during the last quarter. KBC Group NV lifted its stake in shares of Surgery Partners by 31.8% in the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after purchasing an additional 576 shares in the last quarter. DekaBank Deutsche Girozentrale grew its holdings in shares of Surgery Partners by 102.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock worth $80,000 after purchasing an additional 1,375 shares during the period. Point72 Asia Singapore Pte. Ltd. increased its position in Surgery Partners by 747.6% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock worth $124,000 after purchasing an additional 3,379 shares in the last quarter. Finally, Creative Planning purchased a new position in Surgery Partners in the third quarter valued at approximately $258,000.

Surgery Partners Price Performance

SGRY stock opened at $23.00 on Wednesday. The stock’s 50 day moving average is $28.61 and its two-hundred day moving average is $28.21. Surgery Partners, Inc. has a 52-week low of $21.36 and a 52-week high of $36.92. The company has a market capitalization of $2.92 billion, a PE ratio of -47.92, a P/E/G ratio of 19.82 and a beta of 2.58. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). The company had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company’s revenue was up 14.3% on a year-over-year basis. During the same period in the prior year, the company earned $0.15 earnings per share. Analysts predict that Surgery Partners, Inc. will post 0.73 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

SGRY has been the subject of several research reports. JPMorgan Chase & Co. decreased their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research note on Tuesday. Citigroup lowered their price target on Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a report on Wednesday, August 7th. Macquarie restated an “outperform” rating and set a $34.00 price objective on shares of Surgery Partners in a research note on Tuesday, November 19th. StockNews.com lowered Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th. Finally, Royal Bank of Canada reduced their price target on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 20th. One analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Surgery Partners presently has a consensus rating of “Moderate Buy” and an average price target of $37.38.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.